UnitedHealth Group (UNH) Q1 2025 10-Q Quarterly Report
UnitedHealth Group (UNH) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on May 7, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
UnitedHealth Group Q1 2025 10-Q Analysis
Management Discussion & Analysis
- • No revenue or YoY change data disclosed in text
- • No profitability or margin figures provided
- • No segment or product line performance data presented
- • No changes in cash position, operating cash flow, or capital deployment mentioned
- • Management highlights various risks and uncertainties impacting future results and outlook, no updated guidance provided
Risk Factors
- • No new risk factors added this quarter; consistent with 2024 10-K disclosures
- • No material updates to existing risk factors since the 2024 10-K
- • Key regulatory risk includes ongoing compliance with complex healthcare laws as detailed in the 2024 10-K
- • Market risk: competitive pressures and healthcare cost inflation remain significant challenges
- • Financial risk: liquidity and debt maturity profiles unchanged from 2024 10-K disclosures
UnitedHealth Group Q1 2025 Quarterly FinancialsXBRL
Revenue
$109.6B
▲ +9.8% YoY
Net Income
$6.3B
▲ +546.6% YoY
Net Margin
5.7%
▲ +715bp YoY
Source: XBRL data from UnitedHealth Group Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other UnitedHealth Group Quarterly Reports
Get deeper insights on UnitedHealth Group
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.